Manchester Management

Manchester Management's James Besser this week sent a letter to the company's board and shareholders asserting that management had moved the date of Vermillion's annual meeting to make difficult any action by shareholders dissatisfied by the poor performance of the firm's stock.

An exchange this week between Vermillion and the Boston-based hedge fund that holds a nearly 10 percent stake in the company has exposed a rift between the company's management and one of its largest shareholders.

The shareholder wants to make it easier to make changes to Vermillion's management team and board amid a drop in the company's share price over the past year.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.